Shares of Crispr Therapeutics $CRSP have completed a price bottom and could be a candidate for buying-on-the-dip. CRSP Daily Chart (click to enlarge) Price Bottom:- As we can see on the daily chart above, price action was in a bearish channel in the second half of 2018. - After the dip in December, price stabilized and eventually broke above the channel in late February. - What's even more important is the fact that price pushed above the resistance just above $40. - Furthermore, the RSI pushed above 60, which shows lost of the prevailing bearish momentum. It also tagged 70, which reflects the start of bullish momentum.- We can also say that the price action since October represents a price bottom with the neckline at $40 being broken. - The break is not that strong and price is still under the 200-day simple moving average (SMA). - On the other hand, price action already broke some bearish patterns, and we should consider the possible bullish reversal scenario. Pullback, Trade Idea w/ Reward to Risk Assessment:- As price pushed to $42, we saw a bearish divergence between price and the RSI. This could be the precursor to a pullback.- If there is a pullback, I am looking for support around $33.60, a previous resistance.- Also, I would expect the RSI to hold above 40 if CRSP is indeed turning bullish.- A break below $30 would cause a reconsideration of the bullish outlook, and revive a possible bearish continuation outlook.- Thus, if my entry is around $34, with a stop at $29, and a target of $45, I would have a trade that offers just above a 2:1 reward to risk ratio. I do believe this to be a 50/50 chance (that price goes to $45 before $29, so I think this is a decent trade set up for me. - I think this is a short to medium-term trade that should not take more then 2-3 months to realize. It is possible that price will extend beyond $45, but I think there will be some volatility or consolidation before further upside above $45.